All Comments by Hiroshi Mori

  1. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
  2. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation.
  3. alpha-Synuclein membrane interactions and lipid specificity.
  4. Glucocorticoids in Alzheimer's disease. The story so far.
  5. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
  6. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature.
  7. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
  8. A nucleated assembly mechanism of Alzheimer paired helical filaments.
  9. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases.
  10. No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice.
  11. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes.
  12. Stable association of presenilin derivatives and absence of presenilin interactions with APP.
  13. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
  14. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain.
  15. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.